Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Pemphigus is a group of chronic autoimmune skin diseases characterized by blisters formation on the outer layer of the skin and the mucous membranes. Three clinical forms have been characterized, of which paraneoplastic pemphigus is extremely rare.
Biomarker and diagnostic research for paraneoplastic pemphigus has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for paraneoplastic pemphigus.
79 publications have been identified in PubMed for paraneoplastic pemphigus. Research spans Case Report / Case Series (53%), Review / Meta-Analysis (23%), and Epidemiology / Natural History (8%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 42 | 53% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 4:46 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
18 |
23% |
Disease patterns and progression | 6 | 8% |
Testing and diagnosis research | 4 | 5% |
Other research | 3 | 4% |
Laboratory research | 3 | 4% |
Clinical study results | 2 | 3% |
New treatment approaches | 1 | 1% |
Bear CM (2026). [PMID: 41362865](https://pubmed.ncbi.nlm.nih.gov/41362865/). *JAAD Case Rep*. [Case Report / Case Series]
Shih HY (2026). [PMID: 41239862](https://pubmed.ncbi.nlm.nih.gov/41239862/). *Br J Dermatol*. [Basic Science / Preclinical]
Palma C (2026). [PMID: 41704892](https://pubmed.ncbi.nlm.nih.gov/41704892/). *GE Port J Gastroenterol*. [Case Report / Case Series]
Jingying W (2026). [PMID: 42144736](https://pubmed.ncbi.nlm.nih.gov/42144736/). *Br J Dermatol*. [Other]
Wei R (2026). [PMID: 41929499](https://pubmed.ncbi.nlm.nih.gov/41929499/). *Front Immunol*. [Case Report / Case Series]
Alqaidy D (2026). [PMID: 41483625](https://pubmed.ncbi.nlm.nih.gov/41483625/). *Ann Diagn Pathol*. [Review / Meta-Analysis]
Liskova V (2026). [PMID: 41947209](https://pubmed.ncbi.nlm.nih.gov/41947209/). *World J Surg Oncol*. [Epidemiology / Natural History]
Eriksson D (2026). [PMID: 41519944](https://pubmed.ncbi.nlm.nih.gov/41519944/). *Commun Med (Lond)*. [Basic Science / Preclinical]
Li Y (2026). [PMID: 41383974](https://pubmed.ncbi.nlm.nih.gov/41383974/). *Oncol Lett*. [Case Report / Case Series]
Kappius RH (2026). [PMID: 31536300](https://pubmed.ncbi.nlm.nih.gov/31536300/). *Unknown Journal*. [Review / Meta-Analysis]
AI-curated news mentioning paraneoplastic pemphigus
Updated Jun 5, 2026
A recent study highlights increased mucocutaneous FDG activity in paraneoplastic pemphigus linked to follicular dendritic cell sarcoma, which has transformed from Castleman disease. This research may provide insights into the complex interactions between these rare conditions.
A new study discusses a multidisciplinary management approach for paraneoplastic pemphigus associated with primary peritoneal clear cell carcinoma. This research highlights the complexities of treating this rare condition and emphasizes the need for collaborative care.